Treatment of @entity279 , with special attention to XXXX .

@entity1 @entity279 @entity5 @entity4 @entity75 @entity51 @entity280
OBJECTIVE: @entity279 of the central nervous system are rare @entity5 that can occur as @entity5 of @entity280 . With the availability of magnetic resonance imaging, asymptomatic @entity5 are detected more frequently, especially among @entity1 with @entity280 , and the questions of whether and when these lesions should be treated arise. To identify surgical outcomes and the timing of surgery for @entity279 , we retrospectively analyzed data for a series of 28 consecutive @entity1 whom we surgically treated for @entity279 in the past 10 years. METHODS: All @entity5 were completely removed. Functional grades, according to the McCormick scale, were determined before and after surgery and in follow-up assessments. Several clinical characteristics were correlated with changes in functional grades in follow-up assessments, compared with preoperative grades. RESULTS: Functional grades in follow-up assessments improved for 28.6% of the @entity1 and remained unchanged for 71.4%. No @entity1 was in worse condition, compared with preoperative status. Peritumoral @entity4 on preoperative magnetic resonance imaging scans was correlated with significantly higher surgical morbidity rates. Four asymptomatic @entity1 were surgically treated because of @entity5 or pseudocyst progression on serial magnetic resonance imaging scans. All of those @entity1 remained asymptomatic postoperatively. CONCLUSION: @entity279 can be removed with low surgical morbidity rates and excellent long-term prognoses. The timing of surgery for @entity1 with @entity280 and @entity75 remains a matter of debate. On the basis of our data, we established the strategy of operating also on asymptomatic lesions that exhibit radiological progression, before significant @entity51 occur, which are often not reversible.
